why choose us

First received: July 27, 2022

Clinical Trial: Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Psoriasis

Study Type: INTERVENTIONAL


Official Title: A Phase 3B/4, Multicenter, Randomized, Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Moderate-to-severe Scalp Psoriasis (PSORIA

Brief Summary: The purpose of this study is to compare the efficacy and safety of deucravacitinib to placebo in participants with moderate-to-severe scalp psoriasis.

Read more